Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia
Andrea Fabbrini,1 Andrea Guerra2 1Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy; 2IRCCS Neuromed, Pozzilli, IS, ItalyCorrespondence: Andrea GuerraIRCCS Neuromed, Sapienza University of Rome, Via Atinense 18, Pozzilli, 86077, IS, ItalyEmail andrea.guerra@uniroma1.itAbstr...
Saved in:
Main Authors: | Fabbrini A (Author), Guerra A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphodiesterase 10A Inhibition Modulates the Corticostriatal Activity and L-DOPA-Induced Dyskinesia
by: Rayanne Poletti Guimarães, et al.
Published: (2022) -
Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia
by: Andrea Lopez-Lopez, et al.
Published: (2023) -
Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model
by: Maurício dos Santos Pereira, et al.
Published: (2022) -
Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation
by: Mario Gustavo Murer, et al.
Published: (2011) -
Contributive Role of TNF-α to L-DOPA-Induced Dyskinesia in a Unilateral 6-OHDA Lesion Model of Parkinson's Disease
by: Maurício dos Santos Pereira, et al.
Published: (2021)